Health Tech Enterprise (HTE), a Cambridge-based health technology consultancy, has expanded its team with two strategic new hires, marking a period of ongoing growth for the company. Joining HTE are Max Bardwell, Head of Business Development, and Ema Douksaite, Health Economist.
Max, formerly of the Medical Technologies Innovation Facility, has significant experience in technology development for both public and private sector organisations. Max will oversee domestic and international business development for HTE, focusing particularly on building new strategic partnerships with industry, academic and governmental organisations in the health technology space.
Ema has been appointed to further develop HTE’s Health Economics service offering. She will be delivering cost benefit impact models, costing tools and health economic evaluation reports to enable innovators to identify market opportunities, secure funding, and gain access to healthcare markets such as the NHS. Prior to joining HTE, Ema contributed to the OECD Strategic Public Health Planning COVID-19 model by analysing multi-country economic responsiveness to teleworking practices.
Commenting on the company’s continued expansion, Dr Anne Blackwood, HTE’s CEO said: “We offer a full-range of services to support medical technology innovators throughout the product development journey, from concept to commercialisation and final roll-out. The appointment of Max and Ema reflects our ability to connect more organisations than ever with the tools they need to provide future-ready innovations to international healthcare markets and our own NHS partners here in the UK.”
Medical innovators and the health technology community will have the opportunity to meet Max and Ema at the HTE MedTech FUTURES conference. The conference returns to Cambridge on 1 March 2023 with a stellar line up of speakers, which includes some of the biggest names in health and technology; Dr Pegah Salashouri Consultant Cardiologist, Royal Papworth NHS Foundation Trust, and Dr Louise Jopling, Eastern Academic Health Science Network, Dr Robert Tansley from Cambridge Innovation Capital and representatives from the University of Cambridge, Age UK and BIVDA.
This year’s conference, sponsored by Venner Shipley, will be held at Wellcome Genome Campus, and offers delegates a unique opportunity to hear from some of the leading experts in the fastest-growing areas of health and medical technology, alongside the perspective of clinicians on where the opportunities are for technology growth and adoption within the NHS.
To secure tickets to the conference please visit: https://www.eventbrite.co.uk/e/medtech-futures-conference-tickets-398794724757?aff=HTEwebsite
